设计,合成和保护性效应评估新特里亚甲基脱酶2激活剂对心肌缺血的保护作用
Fengping Zhao1, Xin Pan2, Xi Chen1
1The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University (Second Military Medical University), Shanghai 200433, China.
ACS medicinal chemistry letters
|July 16, 2025
概括
研究人员发现了激活二甲基脱酶2 (ALDH2) 的新型三醇化合物,通过改善心脏功能和减少心脏损伤,显示出治疗心肌梗塞 (MI) 的前景.
科学领域:
- 药用化学 医学化学
- 心血管药理学心血管药理学
- 生物化学 生物化学
背景情况:
- 心肌梗塞 (MI) 是一个重大的全球健康挑战,死亡率高.
- 现有的心脏病发作治疗方法存在局限性,需要开发新的治疗策略.
- 化脱酶2 (ALDH2) 在细胞保护和能量代谢中起着至关重要的作用,使其成为潜在的MI治疗标.
研究的目的:
- 发现和描述基于三醇的新型阿尔德海德脱酶2 (ALDH2) 激活剂.
- 为了提高ALDH2激活剂的水溶性和激活力.
- 在心肌梗塞的临床前模型中评估这些新型化合物的治疗潜力.
主要方法:
- 利用分子模拟技术来设计和识别潜在的ALDH2激活剂.
- 合成的新型三醇衍生物,包括代表性化合物Z17.
- 评估ALDH2激活折叠,水溶性和体内疗效在肌肉心脏缺血-再输液损伤的小鼠模型中.
主要成果:
- 发现了新的三醇ALDH2激活剂,显著改善了水溶性和活性.
- 化合物Z17的最大ALDH2激活倍数为5.4,超过了阳性对照Alda-1的304%.
- 在体内,Z17显著改善了心脏功能 (排泄分数增加41%,分数缩短36%) 和减少心肌缩 (心脏病发作大小减少38%).
结论:
- 新型的三醇化合物,特别是Z17,代表了一个有前途的ALDH2激活剂的新类.
- 这些发现为开发针对心肌梗塞的ALDH2向疗法提供了坚实的基础.
- 对这些化合物的进一步研究可能会为心脏病发作患者提供更好的治疗方法.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
761
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
761
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
702
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
702
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
01:26Heart Failure Drugs: Inotropic Agents
733
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
733
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K